EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Correction to “Nanobiotechnology‐mediated radioimmunotherapy treatment for triple‐negative breast cancer”

MedComm – Biomaterials and Applications · 2026-12 · 5 (4)

DOI: 10.1002/mba2.70098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MedComm – Biomaterials and Applications, online erschienen am 03.11.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to “Nanobiotechnology‐mediated radioimmunotherapy treatment for triple‐negative breast cancer”. MedComm – Biomaterials and Applications, 5(4). https://doi.org/10.1002/mba2.70098

Vancouver

Correction to “Nanobiotechnology‐mediated radioimmunotherapy treatment for triple‐negative breast cancer”. MedComm – Biomaterials and Applications. 2026;5(4). doi:10.1002/mba2.70098

BibTeX
@article{euvimed2026,
  title = {Correction to “Nanobiotechnology‐mediated radioimmunotherapy treatment for triple‐negative breast cancer”},
  journal = {MedComm – Biomaterials and Applications},
  year = {2026},
  volume = {5},
  number = {4},
  doi = {10.1002/mba2.70098}
}
Kostenlos starten →